These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27696685)

  • 21. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
    Singh A; Batra JK
    Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of β-naphthylalanine end-tags in the enhancement of antiendotoxin activities: Solution structure of the antimicrobial peptide S1-Nal-Nal in complex with lipopolysaccharide.
    Yu HY; Chen YA; Yip BS; Wang SY; Wei HJ; Chih YH; Chen KH; Cheng JW
    Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1114-1123. PubMed ID: 28288781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of endotoxin neutralization by synthetic cationic compounds.
    Andrä J; Gutsmann T; Garidel P; Brandenburg K
    J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins.
    Chen X; Howe J; Andrä J; Rössle M; Richter W; da Silva AP; Krensky AM; Clayberger C; Brandenburg K
    Biochim Biophys Acta; 2007 Oct; 1768(10):2421-31. PubMed ID: 17555705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form.
    Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S
    J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in the development of neutralizing therapies for sepsis].
    Florencia Henning M; Garda H; Bakás L
    Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of small-molecule endotoxin sequestering agents.
    David SA; Sil D
    Subcell Biochem; 2010; 53():255-83. PubMed ID: 20593271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant.
    Sil D; Shrestha A; Kimbrell MR; Nguyen TB; Adisechan AK; Balakrishna R; Abbo BG; Malladi S; Miller KA; Short S; Cromer JR; Arora S; Datta A; David SA
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2811-9. PubMed ID: 17548488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides.
    Tan NS; Ng ML; Yau YH; Chong PK; Ho B; Ding JL
    FASEB J; 2000 Sep; 14(12):1801-13. PubMed ID: 10973930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules.
    David SA
    J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
    Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
    Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of molecular interactions between eosinophil cationic protein and heparin.
    Fan TC; Fang SL; Hwang CS; Hsu CY; Lu XA; Hung SC; Lin SC; Chang MD
    J Biol Chem; 2008 Sep; 283(37):25468-25474. PubMed ID: 18593710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action.
    Rosenfeld Y; Papo N; Shai Y
    J Biol Chem; 2006 Jan; 281(3):1636-43. PubMed ID: 16293630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotoxin neutralizing peptides.
    Jerala R; Porro M
    Curr Top Med Chem; 2004; 4(11):1173-84. PubMed ID: 15279607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supramolecular structure of enterobacterial wild-type lipopolysaccharides (LPS), fractions thereof, and their neutralization by Pep19-2.5.
    Brandenburg K; Heinbockel L; Correa W; Fukuoka S; Gutsmann T; Zähringer U; Koch MH
    J Struct Biol; 2016 Apr; 194(1):68-77. PubMed ID: 26828112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide.
    Bhunia A; Mohanram H; Domadia PN; Torres J; Bhattacharjya S
    J Biol Chem; 2009 Aug; 284(33):21991-22004. PubMed ID: 19520860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Globin attenuates the innate immune response to endotoxin.
    Yang H; Wang H; Bernik TR; Ivanova S; Wang H; Ulloa L; Roth J; Eaton JW; Tracey KJ
    Shock; 2002 Jun; 17(6):485-90. PubMed ID: 12069185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization.
    Mangoni ML; Epand RF; Rosenfeld Y; Peleg A; Barra D; Epand RM; Shai Y
    J Biol Chem; 2008 Aug; 283(34):22907-17. PubMed ID: 18550541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural determinants of the eosinophil cationic protein antimicrobial activity.
    Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
    Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.